NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vect-Horus

Vect-Horus

Private
MarseilleHealthcare & Life Scienceshttps://www.vect-horus.com/

Last Round

Series D

Jan 20, 2021

Total Funding Raised

$14.34M

Company Overview

Vect-Horus is a biotechnology company that develops a targeted drug delivery system intended to enhance the transport of biotherapeutics across biological barriers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug delivery platformblood-brain barrierBBB deliverytargeted drug deliverymolecular vectorsbrain shuttleCNS drug deliveryvector-drug conjugatescentral nervous systemCNSreceptor-mediated transportbiotechnology licensingtheragnostic agentsoncology drug deliverynucleic acid deliveryimaging agent delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vect-Horus Comparables

Compare Vect-Horus with similar companies based on industry and business-model similarity.

Vect-Horus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ossianix
81%
Gate2Brain
81%
ABL Bio, Inc.
77%

Vect-Horus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJan 20, 2021
VC RoundJun 7, 2018
VC RoundMar 22, 2017
VC RoundDec 15, 2014

Key People

Founding team and executive leadership

Carole Imbert

Chief Financial Officer

Executive Team

Vect-Horus Investors

Notable investors and investment history

Vect-Horus investors
InvestorRounds
CAAP CréationVC Round
SCR Provençale et CorseVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2026

    Monthly visitors grew 103% MoM, reaching 1.2K.

  • Feb 18, 2026

    Grew 24% QoQ, from 41 to 51 employees.

Vect-Horus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vect-Horus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vect-Horus's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarseille
Employee Range55
Year Founded2005
Last FundingJan 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.